Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Tella Pharma's TLP0-001 studied in Japanese trial for treatment of pancreatic cancer

May 17, 2017

TPVdelta66R/mIL-2 as a novel immunovirotherapy for melanoma

May 17, 2017

Glenmark Pharmaceuticals cleared to begin phase I study of GBR-1342

May 16, 2017

Advaxis reports data from phase I study of axalimogene filolisbac

May 16, 2017

Immunomic Therapeutics and Annias enter license agreement for cancer immunotherapy technology

May 16, 2017

SB-415286 provides small molecule inhibition of PD-1 transcription

May 15, 2017

rAd.DCN.GM induces antitumor effect in a murine colorectal cancer model

May 12, 2017

NG34scFvPD-1 preclinical data show promise for glioblastoma treatment

May 12, 2017

PACIFIC trial of durvalumab in stage III NSCLC meets PFS primary endpoint

May 12, 2017

Novel anti-CD30 CAR T-cell therapy enters clinical study for T-cell malignancies

May 12, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....